Indigo’s closure of SHINE Clinical Trial

Indigo’s closure of SHINE Clinical Trial

Indigo closed its SHINE clinical trial, marking a significant milestone in the development of innovative healthcare technology. The trial, designed to evaluate the longer-term stability of Indigo’s continuous multi-metabolite (‘CMM’) device, has concluded its phase...

Pin It on Pinterest